EstherAObengMD
Pediatric Hematology & Oncology • Memphis, TNAssistant Member, St. Jude Children's Research Hospital
Dr. Obeng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
262 Danny Thomas Place
MS 354
Memphis, TN 38105Phone+1 901-595-3300Fax+1 901-595-0817
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2010 - 2013- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2007 - 2010
University of Miami Leonard M. Miller School of MedicineClass of 2007
Certifications & Licensure
TN State Medical License 2018 - 2026
MA State Medical License 2010 - 2025- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Disruption of cotranscriptional splicing suggests RBM39 is a therapeutic target in acute lymphoblastic leukemia.Qi Jin, Ethan Harris, Jacquelyn A Myers, Rashid Mehmood, Anitria Cotton
Blood. 2024-12-05 - RNA splicing as a therapeutic target in myelodysplastic syndromes.Chun-Chih Tseng, Esther A Obeng
Seminars in Hematology. 2024-12-01 - 8 citationsSF3B1 mutation and ATM deletion codrive leukemogenesis via centromeric R-loop dysregulation.Martina Cusan, Haifeng Shen, Bo Zhang, Aijun Liao, Lu Yang
The Journal of Clinical Investigation. 2023-09-01
Press Mentions
- Chan Zuckerberg Initiative Grant Supports Single-Cell Study of Rare Inherited DiseaseJanuary 12th, 2023
Celebrating Doctors’ Day: St. Jude Physicians Reflect on Their Career OriginsMarch 30th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
